Respiratory, Limb Muscle Properties, and Physical Performance in Adult Lung Transplant Recipients
1 other identifier
observational
36
1 country
1
Brief Summary
The goal of this observational study is to evaluate respiratory and limb muscle properties in adults awaiting lung transplantation and determine how these measures relate to physical performance, symptoms, and recovery after transplantation. Respiratory and limb muscle weakness may contribute to impaired mobility, frailty, and delayed postoperative recovery, but their specific role in lung transplant candidates is not well understood. Participants will undergo muscle ultrasound imaging at weekly basis, respiratory and limb strength testing, physical performance assessments, and symptom questionnaires once before and after transplantation. Researchers will also collect information from medical records regarding intensive care unit stay, hospital length of stay, rehabilitation participation, and postoperative recovery outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 5, 2026
CompletedFirst Submitted
Initial submission to the registry
July 27, 2026
CompletedFirst Posted
Study publicly available on registry
August 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
August 5, 2026
July 1, 2026
10 months
July 27, 2026
July 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Diaphragm structure
Diaphragm thickness (unit of measure: mm) assessed by ultrasonography
Weekly from baseline through postoperative day 14 (±2 days)
Respiratory Muscle Strength
Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) obtained during maximal respiratory efforts against a one-way valve.
Baseline and at postoperative day 14 (±2 days)
Abdominal muscle structure
Rectus abdominis muscle thickness (measurement unit: mm) assessed by ultrasonography.
Baseline through postoperative day 14 (±2 days)
Limb muscle strength
Handgrip force and knee extension force measured using dynamometry.
At the first baseline visit and postoperative day 14 (±2 days)
Rectus femoris thickness
Rectus femoris muscle thickness (unit of measurement: mm) assessed by ultrasonography.
Baseline through postoperative day 14 (±2 days)
Secondary Outcomes (5)
Five-Repetition Sit-to-Stand Test
Baseline and hospital discharge
Frailty Status
Baseline and at postoperative day 14 (±2 days)
patient-reported symptoms
Baseline and at postoperative day 14 (±2 days)
Six-Minute Walk Distance
Baseline and at hospital discharge, an average of 3 weeks after surgery.
Anxiety
Baseline and at hospital discharge, up to an average of 3 weeks after surgery.
Other Outcomes (3)
Duration of Mechanical Ventilation
From surgery through hospital discharge, up to an average of 3 weeks after surgery.
Intensive Care Unit Length of Stay
From ICU admission through ICU discharge, up to an average of two weeks after surgery.
Hospital Length of Stay
From ICU admission through hospital discharge, up to an average of 3 weeks after surgery.
Study Arms (1)
Adult Lung Transplant Candidates
adults enrolled for in-hospital evaluation for lung transplant and listed for surgery who undergo serial assessments of respiratory and limb muscle properties before transplantation and during the early postoperative period. Assessments include ultrasound imaging, respiratory and limb strength testing, physical performance measures, patient-reported outcomes, and collection of clinical outcomes from the medical record.
Interventions
Participants undergo serial assessments of respiratory and limb muscle structure and function before and after lung transplantation. Assessments include ultrasound imaging of the diaphragm, rectus abdominis, and quadriceps muscles; respiratory muscle strength testing; handgrip strength testing; knee extension strength testing; physical performance measures; and patient-reported outcome questionnaires.
Eligibility Criteria
Adult lung transplant candidates receiving care at UF Shands hospital. Participants are individuals with advanced lung disease undergoing evaluation and treatment while awaiting lung transplantation in the hospital. The study population includes adults who are able to complete study assessments of respiratory and limb muscle function before transplantation and during the early postoperative recovery period.
You may qualify if:
- years or older.
- Hospitalized as potential candidates for single- or bilateral-lung transplant surgery.
- Hemodynamically stable for out-of-bed mobilization
You may not qualify if:
- Baseline cognitive impairment
- History of previous solid organ transplantation or thoracic surgery
- Existing phrenic nerve lesion
- Lower limb amputation or fracture
- External fixators or open wounds of the lower extremities
- Diagnosed neuromuscular disorder.
- Morbid obesity (body mass index \>45 kg/m²).
- Any other medical condition that, in the opinion of the investigators, would make participation unsuitable.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UF Health Shands Medical Center
Gainesville, Florida, 32608, United States
Related Publications (6)
Maury G, Langer D, Verleden G, Dupont L, Gosselink R, Decramer M, Troosters T. Skeletal muscle force and functional exercise tolerance before and after lung transplantation: a cohort study. Am J Transplant. 2008 Jun;8(6):1275-81. doi: 10.1111/j.1600-6143.2008.02209.x. Epub 2008 Apr 29.
PMID: 18444941BACKGROUNDParry SM, El-Ansary D, Cartwright MS, Sarwal A, Berney S, Koopman R, Annoni R, Puthucheary Z, Gordon IR, Morris PE, Denehy L. Ultrasonography in the intensive care setting can be used to detect changes in the quality and quantity of muscle and is related to muscle strength and function. J Crit Care. 2015 Oct;30(5):1151.e9-14. doi: 10.1016/j.jcrc.2015.05.024. Epub 2015 Jun 3.
PMID: 26211979BACKGROUNDHuh S, Cho WH, Kim D, Son BS, Yeo HJ. Clinical impact of preoperative diaphragm dysfunction on early outcomes and ventilation function in lung transplant: a single-center retrospective study. J Intensive Care. 2022 May 15;10(1):23. doi: 10.1186/s40560-022-00614-7.
PMID: 35570300BACKGROUNDLoMauro A, Righi I, Privitera E, Vergari M, Nigro M, Aliverti A, Frykholm P, Tarsia P, Morlacchi L, Nosotti M, Palleschi A. The impaired diaphragmatic function after bilateral lung transplantation: A multifactorial longitudinal study. J Heart Lung Transplant. 2020 Aug;39(8):795-804. doi: 10.1016/j.healun.2020.04.010. Epub 2020 Apr 21.
PMID: 32362476BACKGROUNDKelm DJ, Bonnes SL, Jensen MD, Eiken PW, Hathcock MA, Kremers WK, Kennedy CC. Pre-transplant wasting (as measured by muscle index) is a novel prognostic indicator in lung transplantation. Clin Transplant. 2016 Mar;30(3):247-55. doi: 10.1111/ctr.12683. Epub 2016 Feb 11.
PMID: 26701203BACKGROUNDRozenberg D, Wickerson L, Singer LG, Mathur S. Sarcopenia in lung transplantation: a systematic review. J Heart Lung Transplant. 2014 Dec;33(12):1203-12. doi: 10.1016/j.healun.2014.06.003. Epub 2014 Jun 9.
PMID: 25044057BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 27, 2026
First Posted
August 5, 2026
Study Start
February 5, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
July 1, 2027
Last Updated
August 5, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- 9 months and ending 36 months following article publication.
- Access Criteria
- Investigators whose proposed use of the data has been approved by an independent review committee.
Participant data that underlie the results reported in this article after deidentification.